Franz Hefti

Franz F.
Hefti was the founder of Limerick BioPharma, Inc., founded in 2004, and Cognition Therapeutics, Inc., founded in 2007, where the title held was Chairman from 2007 to 2013.
Current jobs include Chairman at Spinogenix, Inc., Director at Cadent Therapeutics, Inc., Director at FAAH Pharma, Inc. since 2014, and Director at Sophren, Inc. Former jobs include President, Chief Executive Officer & Director at Acumen Pharmaceuticals, Inc.; Chief Executive Officer at Prevail Therapeutics, Inc. from 2018 to 2023; Director-Neuroscience Research Department at Genentech, Inc. from 1992 to 1995; Director at Embera NeuroTherapeutics, Inc., Annovis Bio, Inc., Covagen AG, Asceneuron SA, Ataxion, Inc., and Chlorion Pharma, Inc. (Chief Development Officer & Vice President); Independent Director at Alzheon, Inc.; Senior Vice President-Neuroscience Research at Merck & Co., Inc. from 1995 to 2002; Chief Scientific Officer at Avid Radiopharmaceuticals, Inc. from 2007 to 2010; Chief Operating Officer at Proclara Biosciences, Inc. from 2017 to 2018; Executive Vice President-Drug Development at Rinat Neuroscience Corp.
from 2003 to 2006; Professor at the University of Southern California; Associate Professor at the University of Miami.
Education includes a doctorate from the University of Zurich.